Bergman RN - Search Results

1

The W64R variant of the beta3-adrenergic receptor is not associated with type II diabetes or obesity in a large Finnish sample.

Ghosh S, Langefeld CD, Ally D, Watanabe RM, Hauser ER, Magnuson VL, Nylund SJ, Valle T, Eriksson J, Bergman RN, Tuomilehto J, Collins FS, Boehnke M. Ghosh S, et al. Among authors: bergman rn. Diabetologia. 1999 Feb;42(2):238-44. doi: 10.1007/s001250051144. Diabetologia. 1999. PMID: 10064105 Free article.

2

Modeling of insulin action in vivo.

Bergman RN, Steil GM, Bradley DC, Watanabe RM. Bergman RN, et al. Annu Rev Physiol. 1992;54:861-83. doi: 10.1146/annurev.ph.54.030192.004241. Annu Rev Physiol. 1992. PMID: 1562195 Review. No abstract available.

3

Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans.

Haffner SM, Stern MP, Watanabe RM, Bergman RN. Haffner SM, et al. Among authors: bergman rn. Eur J Clin Invest. 1992 Mar;22(3):147-53. doi: 10.1111/j.1365-2362.1992.tb01819.x. Eur J Clin Invest. 1992. PMID: 1582438

4

Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.

Watanabe RM, Vølund A, Bergman RN. Watanabe RM, et al. Among authors: bergman rn. Diabetes Care. 1991 Nov;14(11):1021-30. doi: 10.2337/diacare.14.11.1021. Diabetes Care. 1991. PMID: 1797482

5

Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics.

Watanabe RM, Volund A, Roy S, Bergman RN. Watanabe RM, et al. Among authors: bergman rn. J Clin Endocrinol Metab. 1989 Oct;69(4):790-7. doi: 10.1210/jcem-69-4-790. J Clin Endocrinol Metab. 1989. PMID: 2674187

6

Insulin sensitivity accounts for glucose and lactate kinetics after intravenous glucose injection.

Watanabe RM, Lovejoy J, Steil GM, DiGirolamo M, Bergman RN. Watanabe RM, et al. Among authors: bergman rn. Diabetes. 1995 Aug;44(8):954-62. doi: 10.2337/diab.44.8.954. Diabetes. 1995. PMID: 7622002

7

Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors.

Watanabe RM, Azen CG, Roy S, Perlman JA, Bergman RN. Watanabe RM, et al. Among authors: bergman rn. J Clin Endocrinol Metab. 1994 Nov;79(5):1277-83. doi: 10.1210/jcem.79.5.7962320. J Clin Endocrinol Metab. 1994. PMID: 7962320 Clinical Trial.

8

A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.

Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD, Sands RE, Pei D, Savage PJ, Bergman RN. Saad MF, et al. Among authors: bergman rn. Diabetes. 1994 Sep;43(9):1114-21. doi: 10.2337/diab.43.9.1114. Diabetes. 1994. PMID: 8070611

9

Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.

Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN. Wing RR, et al. Among authors: bergman rn. Diabetes Care. 1994 Jan;17(1):30-6. doi: 10.2337/diacare.17.1.30. Diabetes Care. 1994. PMID: 8112186 Clinical Trial.

10

Role of glucose effectiveness in the determination of glucose tolerance.

Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN. Best JD, et al. Among authors: bergman rn. Diabetes Care. 1996 Sep;19(9):1018-30. doi: 10.2337/diacare.19.9.1018. Diabetes Care. 1996. PMID: 8875104 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters